Cocrystal Pharma Inc (COCP) stock has gained 276.09% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives COCP stock a score of 66 out of a possible 100.
That rank is primarily influenced by a fundamental score of 89. In addition to the average rating from Wall Street analysts, COCP stock has a mean target price of 4.75. This means analysts expect the stock to rise 174.57% over the next 12 months. COCP's rank also includes a short-term technical score of 80. The long-term technical score for COCP is 28.
What's Happening with COCP Stock Today
Cocrystal Pharma Inc (COCP) stock has risen 33.08% while the S&P 500 has fallen -0.26% as of 10:34 AM on Wednesday, Nov 25. COCP has gained $0.43 from the previous closing price of $1.30 on volume of 24,854,346 shares. Over the past year the S&P 500 has risen 15.46% while COCP has gained 276.09%. COCP lost -$1.58 per share in the over the last 12 months.
Click Here to get the full Stock Score Report on Cocrystal Pharma Inc (COCP) Stock.
